Radiccthelial cells might have a utility in OA, but most of the endothelial cell targeted tracers were investigated in cancer patients.PET tracers targeting VEGF/VEGFR pathway: Bevacizumab is a monoclonal antibody directed against VEGF-A. Here, VEGFA is linked to cancer.